SS
MED icon

SBI Securities’s Medifast MED Stock Holding History

SBI Securities’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$849 Buy
80
+5
+7% +$58 ﹤0.01% 2857
2026
Q1 		$764 Hold
75
– – ﹤0.01% 2752
2025
Q4 		$801 Sell
75
-12
-14% -$144 ﹤0.01% 2723
2025
Q3 		$1.19K Sell
87
-7
-7% -$98 ﹤0.01% 2621
2025
Q2 		$1.32K Sell
94
-54
-36% -$710 ﹤0.01% 2557
2025
Q1 		$2K Buy
148
+11
+8% +$165 ﹤0.01% 2291
2024
Q4 		$2.41K Buy
+137
New +$2.54K ﹤0.01% 2227

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

SBI Securities's MED Position: Q2 2026 in Review

SBI Securities increased its Medifast (MED) stake by 6.7% in Q2 2026, buying an estimated $58 and bringing the position to 80 shares worth $849. The position accounts for ﹤0.01% of the portfolio, ranked #2857.

SBI Securities first reported a position in MED in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.41K in Q4 2024. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • SBI Securities held 80 shares of Medifast worth $849 as of Q2 2026.
  • SBI Securities bought 5 Medifast shares in Q2 2026, an estimated $58.
  • Medifast made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2857 holding.
  • SBI Securities first reported a position in Medifast in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Medifast position peaked at $2.41K in Q4 2024.
  • 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.